Fabian Kiessling spends much of his time researching Nanomedicine, Drug delivery, Targeted drug delivery, Angiogenesis and Cancer research. His studies in Nanomedicine integrate themes in fields like Molecular imaging, Clinical trial, Computational biology and Intensive care medicine. Fabian Kiessling combines subjects such as Tumor targeting, Biomedical engineering, Microbubbles and Drug with his study of Drug delivery.
The subject of his Targeted drug delivery research is within the realm of Pharmacology. His work carried out in the field of Angiogenesis brings together such families of science as Receptor tyrosine kinase, Vascular endothelial growth factor, Glioma and Cell biology. His research integrates issues of Cell growth, Hepatic stellate cell, CXCL10, CCL20 and Immunology in his study of Cancer research.
Fabian Kiessling focuses on Pathology, Microbubbles, Biomedical engineering, Molecular imaging and Cancer research. His studies deal with areas such as Magnetic resonance imaging, Ex vivo, Angiogenesis and Vascular endothelial growth factor as well as Pathology. His Microbubbles study integrates concerns from other disciplines, such as Drug delivery and Ultrasound imaging.
Fabian Kiessling focuses mostly in the field of Drug delivery, narrowing it down to matters related to Drug and, in some cases, Nanomedicine. His Molecular imaging research focuses on Medical physics and how it relates to Medical imaging. His Cancer research research is multidisciplinary, incorporating perspectives in Cancer and Immune system.
Fabian Kiessling mainly focuses on Cancer research, Molecular imaging, Drug delivery, Microbubbles and Pathology. His Molecular imaging research includes themes of Big data, Medical physics and Medical imaging. His Targeted drug delivery study, which is part of a larger body of work in Drug delivery, is frequently linked to Context, bridging the gap between disciplines.
In his study, Magnetic resonance imaging is strongly linked to Biomedical engineering, which falls under the umbrella field of Microbubbles. His Pathology study combines topics in areas such as Preclinical imaging, Extracellular matrix and Kidney. His study looks at the relationship between Nanomedicine and fields such as Nanocarriers, as well as how they intersect with chemical problems.
His primary areas of investigation include Drug delivery, Nanomedicine, Microbubbles, Biomedical engineering and Cancer research. His work on Targeted drug delivery is typically connected to Methacrylamide as part of general Drug delivery study, connecting several disciplines of science. His Nanomedicine study incorporates themes from Cancer, Immunotherapy, Clinical trial, Intensive care medicine and Nanocarriers.
Fabian Kiessling interconnects Blood flow, Endothelial activation, VCAM-1 and Endothelial dysfunction in the investigation of issues within Microbubbles. Many of his studies on Biomedical engineering involve topics that are commonly interrelated, such as Ultrasound. His work deals with themes such as Immune checkpoint, Cell, Metastasis, Macrophage polarization and FOXP3, which intersect with Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Twan Gerardus Gertudis Maria Lammers;F. Kiessling;W.E. Hennink;Gerrit Storm;Gerrit Storm.
Journal of Controlled Release (2012)
Vascular normalization in Rgs5-deficient tumours promotes immune destruction
Juliana Hamzah;Manfred Jugold;Fabian Kiessling;Paul Rigby.
MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1
Andreas Schober;Maliheh Nazari-Jahantigh;Yuanyuan Wei;Kiril Bidzhekov.
Nature Medicine (2014)
MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages
Maliheh Nazari-Jahantigh;Yuanyuan Wei;Heidi Noels;Shamima Akhtar.
Journal of Clinical Investigation (2012)
Tumor targeting via EPR: Strategies to enhance patient responses
Susanne K. Golombek;Jan Niklas May;Benjamin Theek;Lia Appold.
Advanced Drug Delivery Reviews (2018)
Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner
Chunfu Zhang;Manfred Jugold;Eva C. Woenne;Twan Lammers.
Cancer Research (2007)
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis
Amir Abdollahi;Minglun Li;Minglun Li;Gong Ping;Gong Ping;Christian Plathow.
Journal of Experimental Medicine (2005)
Nanotheranostics and image-guided drug delivery: current concepts and future directions.
Twan Lammers;Fabian Kiessling;Wim E. Hennink;Gert Storm.
Molecular Pharmaceutics (2010)
MRI-Based Attenuation Correction for Hybrid PET/MRI Systems: A 4-Class Tissue Segmentation Technique Using a Combined Ultrashort-Echo-Time/Dixon MRI Sequence
Yannick Berker;Jochen Franke;André Salomon;Moritz Palmowski.
The Journal of Nuclear Medicine (2012)
Core-crosslinked polymeric micelles: principles, preparation, biomedical applications and clinical translation
Marina Talelli;Matthias Barz;Cristianne J.F. Rijcken;Fabian Kiessling.
Nano Today (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: